SEC Form 4 · accession 0001209191-16-137896
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Walbert
Officer — Chairman, President and CEO · Director
Period of report
Aug 18, 2016
Accepted (ET)
Aug 19, 2016 · 11:29 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 18, 2016 | M | 8,330 | $2.40 | A | 334,874 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.40 | Aug 18, 2016 | M | 8,330 | D | — | Jan 1, 2023 | Ordinary Shares | 8,330 | 138,670 | D |
Explanation of responses
- F1Includes 2,051 ordinary shares of the Issuer acquired by the reporting person on June 1, 2016 pursuant to an employee stock purchase program.
- F2The option vests and becomes exercisable in 48 equal monthly installments following the date of grant (January 2, 2013).